Biggest News Aggregation in the World
📰 Tryp Therapeuticsview News

Tryp Therapeuticsview News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Tryp Therapeuticsview. Real-time updates on events, politics, business and more.

Tryp Therapeutics Submits Investigational New Drug Application to US FDA for Planned Phase 2a Clinical Trial in Patients With IBS at Massachusetts General Hospital

KELOWNA, BC / ACCESSWIRE / May 24, 2023 / Tryp Therapeutics, Inc. (CSE:TRYP)(OTCQB:TRYPF) ("Tryp" or the "Company"), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin
United States British Columbia Tryp Therapeuticsview Gewinn Nur Jim Gilligan Peter Molloy

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science